Short Interest in Impel Pharmaceuticals Inc. (NASDAQ:IMPL) D

Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 505,100 shares, a drop of 12.7% from the August 15th total of 578,800 shares. Currently, 6.5% of the company’s stock are short sold. Based on an average daily volume […]

Related Keywords

United States , , Impel Pharmaceuticals , Tower Research Capital , Impel Pharmaceuticals Inc , Institutional Investors Weigh In On Impel Pharmaceuticals , News Ratings For Impel Pharmaceuticals Daily , Nasdaq , Raymond James Associates , Goldman Sachs Group Inc , Impel Pharmaceuticals Company Profile , Impel Pharmaceuticals Trading Down , Citadel Advisors , Get Free Report , Pharmaceuticals Trading Down , Research Capital , Sachs Group , Street Group , Raymond James , Pharmaceuticals Inc , Impel Pharmaceuticals Daily , Nasdaq Impl , Simpl , Medical , Stocks , Options , Put , Call ,